doxazosin 4 mg
1 INDICATIONS AND USAGE Doxazosin tablets are an alpha 1 adrenergic antagonist indicated for: Signs and symptoms of Benign Prostatic Hyperplasia (BPH) Treatment of Hypertension 1.1 Benign Prostatic Hyperplasia (BPH) Doxazosin tablets are indicated for the treatment of the signs and symptoms of BPH. 1.2 Hypertension Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC). Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly. Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal. Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. Doxazosin tablets may be used alone or in combination with other antihypertensives.
aurobindo pharma limited
Related Pills
doxazosin 8 mg
aurobindo pharma limited
doxazosin 2 mg
aurobindo pharma limited
doxazosin 1 mg
aurobindo pharma limited
stay awake caffeine 500 mg
shield pharmaceuticals corp
stay awake caffeine 500 mg
shield pharmaceuticals corp
crestor rosuvastatin calcium tablet film coated
astrazeneca pharmaceuticals lp
crestor rosuvastatin calcium tablet film coated
astrazeneca pharmaceuticals lp
crestor rosuvastatin calcium 20 mg
astrazeneca pharmaceuticals lp
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Doxazosin Tablets, USP are available as tablets for oral administration. Each tablet contains
DOXAZOSIN MESYLATE, USP equivalent to 1 mg, 2 mg, 4 mg or 8 mg of doxazosin as the free base. The 1 mg tablets are a white to off white, round, biconvex tablet debossed with ''D1" on one side and score on the other side of the tablet. They are available as follows: Bottles of 100 NDC 59651-892-01 Bottles of 1,000 NDC 59651-892-99 The 2 mg tablets are a pink, round, biconvex tablet debossed with ''D2" on one side and score on the other side of the tablet. They are available as follows: Bottles of 100 NDC 59651-893-01 Bottles of 1,000 NDC 59651-893-99 The 4 mg tablets are a blue, round, biconvex tablet debossed with ''D4" on one side and score on the other side of the tablet. They are available as follows: Bottles of 100 NDC 59651-894-01 Bottles of 1,000 NDC 59651-894-99 The 8 mg tablets are a purple, round, biconvex tablet debossed with ''D8" on one side and score on the other side of the tablet. They are available as follows: Bottles of 100 NDC 59651-895-01 Bottles of 1,000 NDC 59651-895-99 Recommended Storage: Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
More pills like ROUND D4